Immunological studies in the hyper-immunoglobulin D syndrome

• Published in: Journal of clinical immunology Vol. 12; no. 6; pp. 424 - 428
• Main Authors: HARALDSSON, A, WEEMAES, C. M. R, DE BOER, A. W, BAKKEREN, J. A. J. M, STOELINGA, G. B. A
• Format: Journal Article
• Language: English
• Published: New York, NY Kluwer/Plenum 01-11-1992
• Subjects: Adolescent; Biological and medical sciences; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Hypergammaglobulinemia - immunology; Immunoglobulin D - blood; Immunoglobulin kappa-Chains - blood; Immunoglobulin lambda-Chains - blood; Immunoglobulins - blood; Immunological methods for diagnosis and exploration; Immunopathology; Male; Medical sciences; Serological tests; Syndrome; Human; Immunoglobulinemia; Immunopathology; Immunoglobulins; Immune response; IgD; light-Peptide chain; Hemopathy; Cellular immunity; Assay; Serum; Detection; Child; Humoral immunity
• ISSN: 0271-9142; 1573-2592
• DOI: 10.1007/BF00918854

Five patients with hyper-immunoglobulin D syndrome (hyper-IgD syndrome) were followed up for 3 to 8 years. In all patients studied, serum IgG3 was high. IgM decreased during the follow-up in all patients. In four of the patients serum IgA was elevated. In four patients the serum IgD kappa/lambda ratio was measured and was found to be raised in all. However, the serum total light-chain ratio and IgG, IgA, and IgM kappa/lambda ratios separately were virtually normal. In two of the patients, clinical symptoms preceded the increase in serum IgD. All patients had a history of severe reactions on immunizations in early childhood. We conclude that in hyper-IgD syndrome, other immunoglobulins may also be affected, in particular, IgA, IgM, and IgG3. The IgD light-chain ratio is also disturbed. We emphasize that clinical symptoms may herald immunological changes. This may be the result of an underlying factor causing both the clinical symptoms and, later, the increasing serum IgD levels.